These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The clinical features of juvenile dermatomyositis: A single-centre inception cohort. Cancarini P, Nozawa T, Whitney K, Bell-Peter A, Marcuz JA, Taddio A, Guo J, Dover S, Feldman BM. Semin Arthritis Rheum; 2022 Dec; 57():152104. PubMed ID: 36183479 [Abstract] [Full Text] [Related]
3. Characterization of the biomarkers related to the clinical course and outcomes of juvenile dermatomyositis. Lin TW, Hu YC, Chiang BL. J Microbiol Immunol Infect; 2023 Apr; 56(2):416-423. PubMed ID: 36572597 [Abstract] [Full Text] [Related]
4. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population. Manwatkar A, Padiyar S, Nair A, Jha A, Kumar S, Yadav B, Prakash JAJ, Das JK, Mathew J. Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141 [Abstract] [Full Text] [Related]
5. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center. Nitiyarom R, Charuvanij S, Likasitwattanakul S, Thanoophunchai C, Wisuthsarewong W. Indian J Dermatol Venereol Leprol; 2022 Dec; 88(2):162-170. PubMed ID: 34491668 [Abstract] [Full Text] [Related]
6. Juvenile dermatomyositis: a tertiary center experience. Barut K, Aydin PO, Adrovic A, Sahin S, Kasapcopur O. Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540 [Abstract] [Full Text] [Related]
7. Juvenile dermatomyositis: a case of delayed recognition with unusual complication of nephrocalcinosis. Sangeetha G, Dhanabal D, Mouttou Prebagarane S, Janarthanan M. BMJ Case Rep; 2021 Apr 01; 14(4):. PubMed ID: 33795282 [Abstract] [Full Text] [Related]
9. Angioedema-like presentation as the presenting finding of juvenile myositis and juvenile dermatomyositis in 2 patients. Karaca Ö, Güngör M, Sakarya Güneş A, Eser Şimşek I, Anık Y, Kara B. Int J Rheum Dis; 2022 May 01; 25(5):617-625. PubMed ID: 35238477 [Abstract] [Full Text] [Related]
11. Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry. Carriquí-Arenas S, Mosquera JM, Quesada-Masachs E, López M, Clemente D, Boteanu A, Udaondo C, de Inocencio J, Nieto JC, Riancho L, Núñez E, Sánchez-Manubens J, Lirola MJ, Roldán R, Camacho M, Martínez M, Medrano M, Alcañiz P, Antón J, Iglesias E. Pediatr Rheumatol Online J; 2024 Jul 22; 22(1):66. PubMed ID: 39039532 [Abstract] [Full Text] [Related]
12. Juvenile dermatomyositis in Thai children. Singalavanija S, Liamsuwan S, Limpongsanurak W, Raungsuwan S. J Med Assoc Thai; 2001 Nov 22; 84(11):1527-33. PubMed ID: 11853294 [Abstract] [Full Text] [Related]
15. Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report. Yoshida S, Matsumoto H, Fujita Y, Yokose K, Temmoku J, Matsuoka N, Yashiro-Furuya M, Asano T, Sato S, Suzuki E, Yago T, Yaguchi T, Aita T, Kusano M, Yamamoto T, Watanabe H, Migita K. Tohoku J Exp Med; 2022 Apr 20; 256(4):303-308. PubMed ID: 35296571 [Abstract] [Full Text] [Related]
16. 14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report. Kinkor M, Hameed S, Kats A, Slowik V, Fox E, Ibarra M. Pediatr Rheumatol Online J; 2024 Sep 17; 22(1):86. PubMed ID: 39289679 [Abstract] [Full Text] [Related]
17. [Juvenile dermatomyositis: A series of 22 cases]. Moegle C, Lipsker D. Ann Dermatol Venereol; 2020 Sep 17; 147(8-9):494-503. PubMed ID: 32532518 [Abstract] [Full Text] [Related]
18. Anasarca as the presenting symptom of juvenile dermatomyositis: a case series. Schildt EE, De Ranieri D. Pediatr Rheumatol Online J; 2021 Aug 13; 19(1):120. PubMed ID: 34389019 [Abstract] [Full Text] [Related]
19. The arthritis of inflammatory childhood myositis syndromes. Tse S, Lubelsky S, Gordon M, Al Mayouf SM, Babyn PS, Laxer RM, Silverman ED, Schneider R, Feldman BM. J Rheumatol; 2001 Jan 13; 28(1):192-7. PubMed ID: 11196524 [Abstract] [Full Text] [Related]